ANNE COLWART: Open Payments
NPI 1013242825 · DESTREHAN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 34 payments from 12 companies in 2025. Trend: 2023 $550 · 2024 $1,062 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $174 |
| Lilly USA, LLC | 9 | $169 |
| PFIZER INC. | 4 | $86 |
| ABBVIE INC. | 3 | $62 |
| Exact Sciences Corporation | 3 | $56 |
| Novo Nordisk Inc | 3 | $56 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $18 |
Products named: FARXIGA, JARDIANCE, MOUNJARO, PREVNAR 20, The Cologuard Plus Collection Kit, UBRELVY, Wegovy, INSPIRE.
Industry payments across LA — which companies pay providers there.
